| Wilber P Yep, MD | |
|
2650 Ridge Ave, Emergency Medicine Rm G909, Evanston, IL 60201-1718 | |
| (847) 570-2114 | |
| (847) 570-1223 |
| Full Name | Wilber P Yep |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2650 Ridge Ave, Evanston, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124194659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | (Illinois) | Primary |
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
A new study, presented today at the American Association for Thoracic Surgery's 99th Annual Meeting, shows that a potential treatment for ischemia- reperfusion injury is safe for humans.
The Life Sciences Discovery Fund today announced nearly $1 million in Matching grants to two Washington-based companies to promote translation of promising treatments for devastating medical conditions from the laboratory to the commercial marketplace.
For almost one hundred years the brain's ,central command, system , whose charge includes controlling the body's cardiorespiratory response to exercise , has been pursued. Animal experiments and functional imaging studies have provided clues to the location of this system, but the underlying electrophysiological activity has never been measured.
The FDA today issued warning letters to three companies that manufacture and market mouth rinse products with claims that they remove plaque above the gum line or promote healthy gums. These claims suggest the products are effective in preventing gum disease when no such benefit has been demonstrated.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
› Verified 9 days ago
| Entity Name | Chicago Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285972505 PECOS PAC ID: 2961640222 Enrollment ID: O20130528000058 |
News Archive
A new study, presented today at the American Association for Thoracic Surgery's 99th Annual Meeting, shows that a potential treatment for ischemia- reperfusion injury is safe for humans.
The Life Sciences Discovery Fund today announced nearly $1 million in Matching grants to two Washington-based companies to promote translation of promising treatments for devastating medical conditions from the laboratory to the commercial marketplace.
For almost one hundred years the brain's ,central command, system , whose charge includes controlling the body's cardiorespiratory response to exercise , has been pursued. Animal experiments and functional imaging studies have provided clues to the location of this system, but the underlying electrophysiological activity has never been measured.
The FDA today issued warning letters to three companies that manufacture and market mouth rinse products with claims that they remove plaque above the gum line or promote healthy gums. These claims suggest the products are effective in preventing gum disease when no such benefit has been demonstrated.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wilber P Yep, MD 2650 Ridge Ave, Evanston Hospital, Evanston, IL 60201-1718 Ph: (847) 570-1206 | Wilber P Yep, MD 2650 Ridge Ave, Emergency Medicine Rm G909, Evanston, IL 60201-1718 Ph: (847) 570-2114 |
News Archive
A new study, presented today at the American Association for Thoracic Surgery's 99th Annual Meeting, shows that a potential treatment for ischemia- reperfusion injury is safe for humans.
The Life Sciences Discovery Fund today announced nearly $1 million in Matching grants to two Washington-based companies to promote translation of promising treatments for devastating medical conditions from the laboratory to the commercial marketplace.
For almost one hundred years the brain's ,central command, system , whose charge includes controlling the body's cardiorespiratory response to exercise , has been pursued. Animal experiments and functional imaging studies have provided clues to the location of this system, but the underlying electrophysiological activity has never been measured.
The FDA today issued warning letters to three companies that manufacture and market mouth rinse products with claims that they remove plaque above the gum line or promote healthy gums. These claims suggest the products are effective in preventing gum disease when no such benefit has been demonstrated.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
› Verified 9 days ago
Michael T. Gillam, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2650 Ridge Ave, Emergency Medicine Rm G909, Evanston, IL 60201 Phone: 847-570-2114 Fax: 847-570-1223 | |
Evan G Laskaris, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2650 Ridge Ave, Division Of Emergency Medicine, Evanston, IL 60201 Phone: 847-570-2114 Fax: 847-570-1223 | |
Irene C. Yao, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2650 Ridge Ave, Evanston, IL 60201 Phone: 847-570-2114 | |
Dr. Anastasia Lvovna Khoubaeva, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2650 Ridge Ave, Evanston Hospital, Evanston, IL 60201 Phone: 847-570-2114 Fax: 847-570-1223 | |
Korie Lynne Zink, MD, MS Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2650 Ridge Ave, Evanston, IL 60201 Phone: 847-570-2114 Fax: 847-570-1223 | |
Yudith Diaz Baez, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2650 Ridge Ave, Evanston, IL 60201 Phone: 847-570-2114 Fax: 847-570-1223 | |
Isaac Kolawole Agboola, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2650 Ridge Ave, Evanston, IL 60201 Phone: 847-570-2114 Fax: 847-570-1223 |